Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth
van den Heuvel, A. Pieter J., Jing, Junping, Wooster, Richard F., Bachman, Kurtis E.·2012·Cancer Biology & Therapy
Cited by (215)
Items 101–200 of 215
- Endogenous glutamine decrease is associated with pancreatic cancer progressionCecilia Roux, Chiara Riganti, Sammy Ferri Borgogno, Roberta Curto, Claudia Curcio, Valeria Catanzaro, Giuseppe Digilio, Sergio Padovan, Maria Paola Puccinelli, Monica Isabello et al. · 2017 · Oncotarget
- T Helper Cell Activation and Expansion Is Sensitive to Glutaminase Inhibition under Both Hypoxic and Normoxic ConditionsZeynep Sener, F. Henning Cederkvist, Roman Volchenkov, Halvor L. Holen, Bjørn Steen Skålhegg · 2016 · PLoS ONE
- Targeting Energy Metabolism in Cancer TreatmentJoanna Kubik, Ewelina Humeniuk, Grzegorz Adamczuk, B Madej, Agnieszka Korga-Plewko · 2022 · International Journal of Molecular Sciences
- Metabolic Signaling Cascades Prompted by Glutaminolysis in CancerRaj Shah, Suzie Chen · 2020 · Cancers
- Oncometabolites—A Link between Cancer Cells and Tumor MicroenvironmentMaksymilian Baryła, Aleksandra Semeniuk-Wojtaś, Letycja Róg, Leszek Kraj, Maciej Małyszko, Rafał Stec · 2022 · Biology
- Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytesJoo Young Kim, Sun‐Hee Heo, Seul Ki Choi, In Hye Song, In Ah Park, Young‐Ae Kim, Hye Seon Park, Suk Young Park, Won Seon Bang, Gyungyub Gong et al. · 2017 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
- Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinomaPrahlad V. Raninga, Yaowu He, Keshava K. Datta, Xue Mei Lu, Uma R. Maheshwari, Pooja Venkat, Chelsea Mayoh, Harsha Gowda, Murugan Kalimutho, John David Hooper et al. · 2022 · Molecular Therapy
- Mutant p53R248Q downregulates oxidative phosphorylation and upregulates glycolysis under normoxia and hypoxia in human cervix cancer cellsIleana Hernández‐Reséndiz, Juan Carlos Gallardo‐Pérez, Ámbar López-Macay, Diana Xochiquetzal Robledo‐Cadena, Enrique Garcı́a-Villa, Patricio Gariglio, Emma Saavedra, Rafael Moreno‐Sánchez, Sara Rodríguez‐Enríquez · 2018 · Journal of Cellular Physiology
- Hypoxia in Cancer and Fibrosis: Part of the Problem and Part of the SolutionY. Romero, Arnoldo Aquíno-Gálvez · 2021 · International Journal of Molecular Sciences
- Warburg and Krebs and related effects in cancerJudith E. Unterlass, Nicola J. Curtin · 2019 · Expert Reviews in Molecular Medicine
- Mechanistic Basis of Glutaminase ActivationYunxing Li, Jon W. Erickson, Clint A. Stalnecker, William P. Katt, Qingqiu Huang, Richard A. Cerione, Sekar Ramachandran · 2016 · Journal of Biological Chemistry
- Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatmentLiang Wang, Wen Peng, Tianming Wu, Pengchi Deng, Yinglan Zhao · 2018 · Cell Death Discovery
- Delta-Tocotrienol Modulates Glutamine Dependence by Inhibiting ASCT2 and LAT1 Transporters in Non-Small Cell Lung Cancer (NSCLC) Cells: A Metabolomic ApproachL. Rajasinghe, Melanie Hutchings, S. Gupta · 2019 · Metabolites
- Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancerChuanfan Zhong, Kaihui Wu, Shuo Wang, Zining Long, Taowei Yang, Weibo Zhong, Xiao Tan, Zixian Wang, Chuanyin Li, Jianming Lü et al. · 2021 · Cell Death and Disease
- Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypesTineke W.H. Meijer, Monika G. Looijen-Salamon, Jasper Lok, Michel M. van den Heuvel, Bastiaan B.J. Tops, Johannes H. A. M. Kaanders, Paul N. Span, Johan Bussink · 2019 · Thoracic Cancer
- Discovery of a Thiadiazole–Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft ModelsM. Raymond V. Finlay, Mark J. Anderton, Andrew Bailey, Scott Boyd, Joanna L. Brookfield, Ceri Cairnduff, Mark D. Charles, Anne Cheasty, Susan E. Critchlow, Janet D. Culshaw et al. · 2019 · Journal of Medicinal Chemistry
- Cancer metabolomics in basic science perspectiveHyuk Nam Kwon, Sehyun Oh, Xing Jin, Yong An, Sunghyouk Park · 2015 · Archives of Pharmacal Research
- Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer ProgressionShams S. M. Tabrez, Torki A. Zughaibi, Mehboob Hoque, Mohd Suhail, Mohammad Imran Khan, Azhar Ullah Khan · 2022 · Molecules
- 1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cellXuanzhu Zhou, Wei Zheng, G. A. Nagana Gowda, Daniel Raftery, Shawn Scott Donkin, Brian J. Bequette, Dorothy Teegarden · 2016 · The Journal of Steroid Biochemistry and Molecular Biology
- Glutaminase inhibitors: a patent reviewCanrong Wu, Lixia Chen, Sanshan Jin, Hua Li · 2018 · Expert Opinion on Therapeutic Patents
- Discovery and optimization of withangulatin A derivatives as novel glutaminase 1 inhibitors for the treatment of triple-negative breast cancerWu-Xi Zhou, Chen Chen, Xiaoqin Liu, Ying Li, Yaolan Lin, Xiu-Tao Wu, Lingyi Kong, Jian‐Guang Luo · 2020 · European Journal of Medicinal Chemistry
- iTRAQ‐Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric CancerZhen Jiang, Chenghua Zhang, Li Gan, Yuewang Jia, Yu Chun Xiong, Yujiang Chen, Zhi Wang, Linfeng Wang, Hao Luo, Juexi Li et al. · 2018 · PROTEOMICS - CLINICAL APPLICATIONS
- A glutamine ‘tug-of-war’: targets to manipulate glutamine metabolism for cancer immunotherapyLaura J. Pallett, Sarah Dimeloe, Linda V. Sinclair, Adam J. Byrne, Anna Schurich · 2021 · Immunotherapy Advances
- Identification and characterization of a novel glutaminase inhibitorHenning Cederkvist, Shrikant Shantilal Kolan, Jonas Aakre Wik, Zeynep Sener, Bjørn Steen Skålhegg · 2021 · FEBS Open Bio
- Targeting glutamine metabolism in myeloproliferative neoplasmsHuichun Zhan, Kristen Ciano, Katherine Dong, Stanley Zucker · 2015 · Blood Cells Molecules and Diseases
- Nutritional Stress in Head and Neck Cancer Originating Cell Lines: The Sensitivity of the NRF2-NQO1 AxisLidija Milković, Marko Tomljanović, Ana Čipak Gašparović, Renata Novak Kujundžić, Dina Šimunić, Paško Konjevoda, Anamarija Mojzeš, Nikola Đaković, Neven Žarković, Koraljka Gall‐Tros̆elj · 2019 · Cells
- Glutamine Transporter SLC1A5 Regulates Ionizing Radiation‐Derived Oxidative Damage and FerroptosisZhuhui Yuan, Tong Liu, Xiao Huo, Hao Wang, Junjie Wang, Lixiang Xue · 2022 · Oxidative Medicine and Cellular Longevity
- SIRT5 Activation and Inorganic Phosphate Binding Reduce Cancer Cell Vitality by Modulating Autophagy/Mitophagy and ROSFederica Barreca, Michele Aventaggiato, Laura Vitiello, Luigi Sansone, Matteo Antonio Russo, Antonello Mai, Sérgio Valente, Marco Tafani · 2023 · Antioxidants
- Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and ProgressionKevinn Eddy, Mohamad Naser Eddin, Anna Fateeva, Stefano Vito Boccadamo Pompili, Raj Shah, Saurav Doshi, Suzie Chen · 2022 · Cells
- PET Imaging of 18F-(2S,4R)4-Fluoroglutamine Accumulation in Breast Cancer: From Xenografts to PatientsFei Liu, Xiaoxia Xu, Hua Zhu, Yan Zhang, Jianhua Yang, Lifang Zhang, Nan Li, Lin Zhu, Hank F. Kung, Zhi Yang · 2018 · Molecular Pharmaceutics
- Amino acid transporter SLC38A5 regulates developmental and pathological retinal angiogenesisZhongxiao Wang, Felix Yemanyi, Alexandra K. Blomfield, Kiran Bora, Shuo Huang, Chi‐Hsiu Liu, William R. Britton, Steve S. Cho, Yohei Tomita, Zhongjie Fu et al. · 2022 · eLife
- Autonomous metabolic reprogramming and oxidative stress characterize endothelial dysfunction in acute myocardial infarctionErika Zodda, Olga Tura-Ceide, Nicholas L. Mills, Josep Tarragó‐Celada, M. Carini, Timothy M. Thomson, Marta Cascante · 2023 · eLife
- Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/ParagangliomasSarkadi, Balazs, Meszaros, Katalin, Krencz, Ildiko, Canu, Letizia, Krokker, Lilla, Zakarias, Sara, Barna, Gabor, Sebestyen, Anna, Papay, Judit, Hujber, Zoltan et al. · 2020 · Cancers
- A Systematic Role of Metabolomics, Metabolic Pathways, and Chemical Metabolism in Lung CancerSandra Kannampuzha, Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Reshma Murali, Arunraj Namachivayam, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Harishkumar Madhyastha et al. · 2023 · Vaccines
- Role and therapeutic targeting of glutamine metabolism in non‑small cell lung cancer (Review)Lei Zhou, Qi Zhang, Qing Zhu, Yuan Zhan, Yong Li, Xuan Huang · 2023 · Oncology Letters
- An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinomaJianguo Bai, Ruifeng Tang, Keyu Zhou, Jialei Chang, Hongyue Wang, Qixin Zhang, Jiahui Shi, Chao Sun · 2022 · BMC Medical Genomics
- Influence of Serum and Hypoxia on Incorporation of [14C]‐ d ‐Glucose or [14C]‐ l ‐Glutamine into Lipids and Lactate in Murine Glioblastoma CellsNathan L. Ta, Thomas N. Seyfried · 2015 · Lipids
- Physapubescin I from husk tomato suppresses SW1990 cancer cell growth by targeting kidney-type glutaminaseKaiyin Yang, Canrong Wu, Mengzhu Zheng, Ruotian Tang, Xingzhou Li, Li-Xia Chen, Hua Li · 2019 · Bioorganic Chemistry
- Identification of informative genes and pathways using an improved penalized support vector machine with a weighting schemeWeng Howe Chan, Mohd Saberi Mohamad, Safaai Deris, Nazar Zaki, Shahreen binti Kasim, Sigeru Omatu, Juan M. Corchado, Hany Alashwal · 2016 · Computers in Biology and Medicine
- FAIM regulates autophagy through glutaminolysis in lung adenocarcinomaTianyu Han, Pengcheng Wang, Yanan Wang, Wenze Xun, Jiapeng Lei, Tao Wang, Zhuo Lü, Mingxi Gan, Wei Zhang, Bentong Yu et al. · 2021 · Autophagy
- Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activatorsClint A. Stalnecker, Jon W. Erickson, Richard A. Cerione · 2017 · Journal of Biological Chemistry
- Therapeutic Potential of Glutamine Pathway in Lung CancerEnyu Tang, SiYang Maggie Liu, Zhiming Zhang, Rixin Zhang, Dejing Huang, Tong Gao, Tianze Zhang, G Xu · 2022 · Frontiers in Oncology
- Aberrant Metabolism as Inductor of Epigenetic Changes in Breast Cancer: Therapeutic OpportunitiesJossimar Coronel-Hernández, Eloy Andrés Pérez-Yépez, Izamary Delgado-Waldo, Carlos Contreras-Romero, Nadia Judith Jacobo-Herrera, David Francisco Cantú-De León, Carlos Pérez‐Plasencia · 2021 · Frontiers in Oncology
- Intratumoral heterogeneity of glutaminase and lactate dehydrogenase A protein expression in colorectal cancerYuta Mizuno, Kimiaki Hattori, Kohei Taniguchi, Keitaro Tanaka, Kazuhisa Uchiyama, Yoshinobu Hirose · 2020 · Oncology Letters
- An updated patent review of glutaminase inhibitors (2019–2022)Danni Wang, Xiaohong Li, Guangyue Gong, Yulong Lu, Ziming Guo, Rui Chen, Huidan Huang, Zhiyu Li, Jinlei Bian · 2023 · Expert Opinion on Therapeutic Patents
- Two Faces of Glutaminase GLS2 in CarcinogenesisJoanna Buczkowska, Monika Szeliga · 2023 · Cancers
- Expression of Metabolism-Related Proteins in Lacrimal Gland Adenoid Cystic CarcinomaJa Seung Koo, Jin Sook Yoon · 2015 · American Journal of Clinical Pathology
- Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain PathwaysJennifer Fazzari, Katja Linher‐Melville, Gurmit Singh · 2016 · Current Neuropharmacology
- Tobacco Smoking Rewires Cell Metabolism by Inducing GAPDH Succinylation to Promote Lung Cancer ProgressionKun Wang, Jingzhuo Li, Hai Zhang, Hongyan Ma, Hong‐Yong Cui, Huai‐Qiang Ju, Jing Zhang, Qing-zhi Ma, Ming Zhao, Qing-mei Zeng et al. · 2025 · Cancer Research
- Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell linesKamal Eltayeb, Roberta R Alfieri, Claudia Fumarola, Mara A. Bonelli, Maricla Galetti, Andrea Cavazzoni, Graziana Digiacomo, Francesca Galvani, Federica Vacondio, Alessio Lodola et al. · 2024 · Biochemical Pharmacology
- High-resolution structures of mitochondrial glutaminase C tetramers indicate conformational changes upon phosphate bindingThuy‐Tien T. Nguyen, Sekar Ramachandran, Matthew J. Hill, Richard A. Cerione · 2022 · Journal of Biological Chemistry
- Mitochondrial substrates in cancer: Drivers or passengers?Björn Kruspig, Boris Zhivotovsky, Vladimir G. Gogvadze · 2014 · Mitochondrion
- Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer CellsFriederike Steifensand, Julia K. S. Gallwas, Gerd Johannes Bauerschmitz, Carsten Gründker · 2021 · Cells
- Inhibition of Glutaminolysis Inhibits Cell Growth via Down-regulating Mtorc1 Signaling in Lung Squamous Cell CarcinomaXulu Ye, Qiliang Zhou, Yoshifumi Matsumoto, Masato Moriyama, Shun Kageyama, Masaaki Komatsu, Seijirou Satoh, Masanori Tsuchida, Yasuo Saijo · 2016 · Anticancer Research
- Sijunzi Tang improves gefitinib resistance by regulating glutamine metabolismZhihong Wang, Taifeng Li, Ruisheng Li, Bo Cao, Shiyuan Wang, Xiaofei Fei, Chunyu Li, Guohui Li · 2023 · Biomedicine & Pharmacotherapy
- Analysis of anti-tumor effect and mechanism of GLS1 inhibitor CB-839 in colorectal cancer using a stroma-abundant tumor modelRyo Miyamoto, Hidehiko Takigawa, Ryo Yuge, Daisuke Shimizu, Misa Ariyoshi, Rina Otani, Akiyoshi Tsuboi, Hidenori Tanaka, Ken Yamashita, Yuichi Hiyama et al. · 2024 · Experimental and Molecular Pathology
- N-terminal phosphorylation of glutaminase C decreases its enzymatic activity and cancer cell migrationCarolline Fernanda Rodrigues Ascenção, Raghavendra Sashi Krishna Nagampalli, Zeyaul Islam, Matheus Pinto Pinheiro, Larissa Menezes dos Reis, Bianca Alves Pauletti, Carolina Aparecida de Guzzi Cassago, Daniela C. Granato, Adriana Franco Paes Leme, Sandra Martha Gomes Dias · 2018 · Biochimie
- Glutaminase potentiates the glycolysis in esophageal squamous cell carcinoma by interacting with PDK1Guangzhao Zhu, Fangxia Guan, Shenglei Li, Qing Hua Zhang, Xueying Zhang, Yue Qin, Zhangzhan Sun, Shaohua Peng, Jiexing Cheng, Yiyang Li et al. · 2024 · Molecular Carcinogenesis
- Metabolic Enzymes in Sarcomagenesis: Progress Toward Biology and TherapyLuyuan Li, Josiane E. Eid, Ana Cristina Paz, Jonathan C. Trent · 2017 · BioDrugs
- Serial deletion reveals structural basis and stability for the core enzyme activity of human glutaminase 1 isoforms: relevance to excitotoxic neurodegenerationYuju Li, Justin Peer, Runze Zhao, Yinghua Xu, Beiqing Wu, Yi Wang, Changhai Tian, Yunlong Huang, Jialin Zheng · 2017 · Translational Neurodegeneration
- Canceromics Studies Unravel Tumor’s Glutamine Addiction After Metabolic ReprogrammingJavier Márquez, José Manuel Matés, Francisco José Alonso, Mercedes Martín‐Rufián, Carolina Lobo, José Angel Campos-Sandoval · 2015 · Springer eBooks
- Glutaminase 1 in mandarin fish Siniperca chuatsi: Molecular characterization, expression pattern and function involving in virus replicationShangui Liu, Ningqiu Li, Qiang Lin, Lihui Liu, Yinjie Niu, Hongru Liang, Zhibin Huang, Xiaozhe Fu · 2020 · Aquaculture
- Lifting the veil on tumor metabolism: A GDH1-focused perspectiveSisi Zhou, Huaer Wu, Yun Chen, Jiawei Lv, Shufang Chen, Hua Yu, Tiezhu Shi, Xiongjun Wang, Lingyun Xiao · 2025 · iScience
- A novel function of anaphase promoting complex subunit 10 in tumor progression in non-small cell lung cancerYanan Wang, Tianyu Han, Mingxi Gan, Meng Guo, Caifeng Xie, Jiangbo Jin, Song Zhang, Pengcheng Wang, Jiaqing Cao, Jian-Bin Wang · 2019 · Cell Cycle
- Stable isotope-resolved metabolomics analyses of metabolic phenotypes reveal variable glutamine metabolism in different patient-derived models of non-small cell lung cancer from a single patientConnor Jarrett Kinslow, Michael Bousamra ll, Yihua Cai, Jun Yan, Pawel Konrad Lorkiewicz, Ahmad Al‐Attar, Jinlian Tan, Richard M. Higashi, Andrew N. Lane, Teresa W.‐M. Fan · 2024 · Metabolomics
- CB-839 induces reversible dormancy in lung tumor-cellsAzemat Jamshidi‐Parsian, Samir V. Jenkins, Amy Tran, Anna Bragg, Rylie Davis, Connor Griffin, Eric R. Siegel, Ruud P.M. Dings, Robert J. Griffin, Gunnar Boysen · 2024 · European Journal of Pharmacology
- circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathwayChangpeng Sun, Hongjun Guan, Jinjin Li, Yinfeng Gu · 2023 · Open Medicine
- Co-treatment with melatonin and ortho-topolin riboside reduces cell viability by altering metabolic profiles in non-small cell lung cancer cellsJi‐Won Lee, Hwanhui Lee, Soon-Wook Noh, Hyung‐Kyoon Choi · 2024 · Chemico-Biological Interactions
- Glutamine metabolism in the proliferation of GS-expression pituitary tumor cellsJintao Hu, Qingbo Chen, Xiao Ding, Xin Zheng, Xuefeng Tang, Song Li, Hui Yang · 2020 · Endocrine Connections
- Metabolic targeting of malignant tumors: a need for systemic approachAggelos T. Margetis · 2022 · Journal of Cancer Research and Clinical Oncology
- Centromere-associated protein E expresses a novel mRNA isoform in acute lymphoblastic leukemia.Cindy E Jiménez-Ávila, Vanessa Villegas-Ruíz, Marta Zapata‐Tarrés, Alejandra Elizabeth Rubio-Portillo, Eleazar I Pérez López, Juan Carlos Zenteno, Sergio Juárez‐Méndez · 2018 · Europe PMC (PubMed Central)
- Glutaminase 1 inhibitors: Therapeutic potential, mechanisms of action, and clinical perspectivesHui Wang, Xiandeng Li, Haitao Hu, Zhan Gao · 2025 · Biochemical Pharmacology
- Pathway metabolite ratios reveal distinctive glutamine metabolism in a subset of proliferating cellsNancy T. Santiappillai, Yue Cao, Mariam F. Hakeem-Sanni, Jean Yee Hwa Yang, Lake‐Ee Quek, Andrew J. Hoy · 2025 · Molecular Systems Biology
- Structure-based virtual screening discovers novel kidney-type glutaminase inhibitorsLi-Chun Lin, Hsin‐Yi Chang, Tony Eight Lin, Jyh-Ruey Lin, Shih‐Min Hsia, Kai‐Cheng Hsu, Tsui‐Chin Huang · 2022 · Biomedicine & Pharmacotherapy
- Glutaminases in slowly proliferating gastroenteropancreatic neuroendocrine neoplasms/tumors (GEP-NETs): Selective overexpression of mRNA coding for the KGA isoformMonika Szeliga, Jarosław Bogdan Ćwikła, Marta Obara‐Michlewska, Andrzej S Cichocki, Jan Albrecht · 2015 · Experimental and Molecular Pathology
- c‐MYC mRNA tail tale about glutamine control of transcriptionChi Van Dang · 2017 · The EMBO Journal
- Metabolic Responses of Lung Adenocarcinoma Cells to Survive under Stressful Conditions Associated with Tumor MicroenvironmentÁngeles Carlos‐Reyes, Susana Romero‐Garcia, Heriberto Prado-Garcı́a · 2024 · Metabolites
- Silencing of miR-23a attenuates hydrogen peroxide (H2O2) induced oxidative damages in ARPE-19 cells by upregulating GLS1: an in vitro studyYang Zhou, Meilibanu Yusufu, Ting Zhang, Jing Wang · 2020 · Cytotechnology
- Reduced Usage of GLS Intronic Polyadenylation Promotes Cellular SenescenceXueping Li, Yuxin Li, Dong Ding, Baiyun Xie, Jun Yao, Yu Chen, Zhaozhao Zhao, Peng Yu, Shengwei Zhang, Yang Fu et al. · 2025 · Phenomics
- Glutaminase I and glutamine transaminase–ω-amidase pathways in colorectal cancer: Metabolic reprogramming and emerging therapeutic strategiesSarah F Voor, Arthur J.L. Cooper, John Thomas Pinto · 2025 · Analytical Biochemistry
- Genetic estimation of correlations between circulating glutamine and cancer.Kai Zhang, Hongjin Liang · 2023 · PubMed Central
- The interplay between lnRNAs, SNPs, and protein complexes - what does it mean for cancer metabolism?Roxana Simona Redis, George A. Călin · 2016 · Molecular & Cellular Oncology
- Micromonosporamide A with Glutamine-Dependent Cytotoxicity from Micromonospora sp. MM609M-173N6: Isolation, Stereochemical Determination, and SynthesisToshifumi Takeuchi, Masaki Hatano, Hideyuki Muramatsu, Yumiko Kubota, Ryûichi Sawa, Masayuki Igarashi · 2021 · Organic Letters
- Integration of single-cell RNA-seq data into metabolic models to characterize tumour cell populationsChiara Damiani, Davide Maspero, Marzia Di Filippo, Riccardo Colombo, Dario Pescini, Alex Graudenzi, Hans Victor Westerhoff, Lilia Alberghina, Marco Vanoni, Giancarlo Mauri · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
- Mitochondrial Metabolomics in Cancer: Mass Spectrometry-Based Approaches for Metabolic Rewiring Analysis and Therapeutic DiscoveryYuqing Gao, Zhirou Xiong, Xinyi Wei · 2025 · Metabolites
- Association between GLS Gene Polymorphisms and the Susceptibility to Lung Cancer in the Chinese Han PopulationYuhe Wang, Mingyue Chen, Faling Yi, Jinpeng Xu, Changchun Liu, Ziyi Zhang, Ping Wang, Tianbo Jin, Mingwei Chen · 2023 · Frontiers in Bioscience-Landmark
- The Bioenergetic Role of Mitochondria in Lung CancerKeely E. FitzGerald, Purna Chaitanya Konduri, Chantal Vidal, Hyuntae Yoo, Zhang Li · 2017 · InTech eBooks
- Metabolic Pathways of Eukaryotes and Connection to Cell MechanicsClaudia Tanja Mierke · 2020 · Biological and medical physics, biomedical engineering
- L-5-[11C]-glutamine PET of breast cancer: Preclinical studies in mouse modelsChristopher Hensley, Prashanth K. Padakanti, R. Damani, C. Dulal, Hoon Choi, Shi-Hong Li, Jianbo Cao, Hsiao-Ju S. Lee, A. Pantel, Elizabeth J. Li et al. · 2025 · Nuclear Medicine and Biology
- WTAP-Mediated Glutaminase Splicing Bias Suppresses Ferroptosis in Hepatocellular CarcinomaCan Zhu, Ke Wu, Ke Wu, Jun Ma, Bo Ding, Nan Jiang, Keyi Du, Guomin Ju, Haiyang Xie, Chuanhui Peng et al. · 2026 · 癌症:英文版
- The Interplay of Splicing and Metabolism in CancerDillon M. Voss, Yange Cui, Peter S. Klein · 2026 · Cells
- Illuminating spatial dynamics of glutamine metabolism with a sensitive genetically encoded biosensorJack M. Scully, Michael J Sun, Siddarth Das, Nataly J. Arias, Edmund D. Kapelczak, Tiffany D. Robinson, Katie G. Vineall, Teagan S. Dean, Tara A. TeSlaa, Ajit S. Divakaruni et al. · 2026 · RSC Chemical Biology
- A Local-Network Guided Linear Discriminant Analysis for Classifying Lung Cancer Subtypes using Individual Genome-Wide Methylation ProfilesYanming Li · 2019 · Advances in intelligent systems and computing
- Lung TumorsHelmut Popper · 2021 · Springer eBooks
- Clinical and biological impact of SNAT7 in lung adenocarcinoma: implications for prognosis and treatmentAsato Hashinokuchi, Naoki Haratake, Yuya Ono, Takumi Tomonaga, Giacomo Bassi, Kyoto Matsudo, Fumihiko Kinoshita, Taichi Matsubara, Mikihiro Kohno, Tomoyoshi Takenaka et al. · 2025 · International Journal of Clinical Oncology
- Splicing factor SF3B4 promotes mitochondrial glutamine metabolism in hepatocellular carcinoma by regulating GLS1 isoform switchingSeungyeon Yang, Minbeom Ko, Wei Zhang, Seung Min Jeong · 2025 · Biochemical and Biophysical Research Communications
- Exosomes loaded with metabolites: Roles in crosstalk between tumor cells and their microenvironmentPing Ye, Mingjun Sun, Jia Wang, Xianzhao Bai, Zihan Li, Qiang Lin, Ran Liu · 2025 · European Journal of Pharmacology
- Structural reassignment of compound 968, an allosteric glutaminase inhibitorLindsey Albertelli, Sainabou Jallow, Chun Li, Scott Michael Ulrich · 2026 · Beilstein Journal of Organic Chemistry
- Comprehensive Analysis of Subtypes and Identification of Key lncRNAs Based on Glutamine Metabolism-Related Long Noncoding RNAsYuwei Feng, Xiaowei Sun, Tiangu Yang, Jingqi Han, Dapeng Zhou, Haitao Ren, Yulong Sheng, Yanhua Wang · 2022 · Computational and Mathematical Methods in Medicine · Retracted
- Sijunzi Tang Enhances The Sensitivity of Lung Cancer Cells To Gefitinib Based On Glutamine MetabolismZhihong Wang, Shiyuan Wang, Xia Liu, Bo Cao, Mingyu Zhang, Chunyu Li, Guohui Li · 2021 · Research Square